Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Mark J. Levis; Harry P. Erba; Pau Montesinos; Radovan Vrhovac; Elzbieta Patkowska; Heeje Kim; Pavel Zak; Po-Nan Wang; Jaime E. Connolly Rohrbach; Ken CN Chang; James Hanyok; Li Liu; Yasser Mostafa Kamel; Arnaud Lesegretain; Jorge E. Cortes; Mikkael A. Sekeres; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Richard F. Schlenk; Alexander Perl

doi:10.1182/blood-2022-162739

Back

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Journal article

Peer reviewed

Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival

Mark J. Levis, Harry P. Erba, Pau Montesinos, Radovan Vrhovac, Elzbieta Patkowska, Heeje Kim, Pavel Zak, Po-Nan Wang, Jaime E. Connolly Rohrbach, Ken CN Chang, …

Blood, Vol.140(Supplement 1), pp.546-548

2022-11-15

DOI: https://doi.org/10.1182/blood-2022-162739

Appears in Miller School of Medicine - Latest Publications

Metrics

1 Record Views

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.155 Acute Myeloid Leukemia
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Quantum-First Trial: FLT3 -ITD-Specific MRD Clearance Is Associated with Improved Overall Survival
Creators: Mark J. Levis - Johns Hopkins University
Harry P. Erba - Duke University
Pau Montesinos - 4Hospital Politecnico Universitario La Fe, Valencia, Spain
Radovan Vrhovac - University Hospital Centre Zagreb
Elzbieta Patkowska - 6Hematology Department, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Heeje Kim - Catholic University of Korea
Pavel Zak - Charles University
Po-Nan Wang - Chang Gung Memorial Hospital
Jaime E. Connolly Rohrbach - Daiichi Sankyo
Ken CN Chang - Daiichi Sankyo
James Hanyok - Daiichi Sankyo
Li Liu - Daiichi Sankyo
Yasser Mostafa Kamel - Daiichi Sankyo
Arnaud Lesegretain - Daiichi Sankyo
Jorge E. Cortes - Augusta University
Mikkael A. Sekeres - Sylvester Comprehensive Cancer Center
Hervé Dombret - Hôpital Saint-Louis
Sergio Amadori - Polyclinic Medical Center
Jianxiang Wang - 17Institute of Hematology, CAMS, Tianjin, China
Richard F. Schlenk - National Center for Tumor Diseases
Alexander Perl - University of Pennsylvania
Publication Details: Blood, Vol.140(Supplement 1), pp.546-548
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031760095302976